))
Ep. 185: Neffy® Approval Update
Manage episode 378083045 series 3392202
Content provided by FAACT's Roundtable Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by FAACT's Roundtable Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Recently, the food allergy community anxiously awaited good news of FDA approval for neffy® (needle-free nasal epinephrine spray), but to the community’s shock, the FDA denied approval. ARS Pharma Co-founder, President and CEO, Richard Lowenthal, joins us to explain what happened and where neffy® stands.
Resources to keep you in the know:
Stay tuned and follow FAACT to learn how you can take action and personally advocate for the approval of neffy® with your local and federal legislators.
You can find the FAACT Roundtable Podcast on Pandora, Apple Podcast, Spotify, Google Podcast, Stitcher, iHeart Radio, Podcast Chaser, Deezer, and Listen Notes.
Visit us at www.FoodAllergyAwareness.org.
Sponsored by: ARS Pharma
Thanks for listening! FAACT invites you to discover more exciting food allergy resources at FoodAllergyAwareness.org!
210 episodes
Share
